Pathology Reporting of Neuroendocrine Tumors: Essential Elements for Accurate Diagnosis, Classification, and Staging

被引:62
|
作者
Klimstra, David S. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
关键词
PANCREATIC ENDOCRINE TUMORS; SMALL-CELL CARCINOMA; MOLECULAR TARGETED THERAPY; HIPPEL-LINDAU-DISEASE; GASTROINTESTINAL-TRACT; PROGNOSTIC-FACTORS; LOW-GRADE; GASTROENTEROPANCREATIC TUMORS; IMMUNOHISTOCHEMICAL ANALYSIS; SOMATOSTATIN ANALOGS;
D O I
10.1053/j.seminoncol.2012.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Much recent debate has focused on the optimal classification of epithelial neuroendocrine tumors (NETs). Multiple different systems of terminology, grading, and staging have been proposed, and some systems combine elements of grade and stage into a single prognostic classification. Recently, national and international consensus groups have attempted to standardize the classification of NETs, especially for those arising in the gastrointestinal tract and pancreas. Furthermore, the recognition that common classification criteria (such as proliferative rate) span multiple different systems allows the basic data necessary to predict outcome and tailor therapy to be included in pathology reports, even though a single uniform system of terminology may remain elusive. Formal tumor-node-metastasis (TNM)-based staging systems also have been developed recently, and advances in the treatment of some NETs (pancreatic in particular) are pointing towards the need to assess therapeutic biomarkers in routine practice. This review will present the most widely used systems for classifying, grading, and staging NETs and will summarize the recommendations for the data to be included in standard pathology reports of these uncommon tumors. © 2013 Elsevier Inc.
引用
收藏
页码:23 / 36
页数:14
相关论文
共 50 条